New Technique Enables Early Detection of Liver Cancer With Fingerprints

Liver cancer can be detected at an early stage with the help of a newly developed technique. By sequencing DNA of liver cells and determining whether the cells have been exposed to a potent carcinogen, researchers have paved the way for diagnosis of the deadly disease. //

Researchers of the Massachusetts Institute of Technology (MIT) have developed a way to identify the carcinogenic cells in the liver.

Favorable Outcome for Minimally Invasive Hepatectomy in Liver Cancer
A minimally invasive approach that avoids the large open incision to perform liver resection may soon be a viable alternative, revealed a new study.

‘Exposure to a fungal product called aflatoxin is believed to cause 80 percent of liver cancer cases. The technique of DNA sequencing enables the cancer to be detected early.’

Tweet it Now

In many parts of the world, exposure to a fungal product called aflatoxin is believed to cause up to 80 percent of liver cancer cases.

This fungus is often found in corn, peanuts, and other crops that are dietary staples in those regions.

The new technique can determine whether liver cells have been exposed to aflatoxin and help predict whether someone has a high risk of developing liver cancer, potentially many years before tumors actually appear.

Analyzing the Circulating Tumor Cells Improve Diagnosis and Monitoring of Liver Cancer
Using an advanced form of polymerase chain reaction (PCR) can analyze circulating tumor cells (CTCs) and may increase the ability to diagnose liver cancer.

"What we're doing is creating a fingerprint," said John Essigmann, Professor at MIT.

"It's really a measure of prior exposure to something that causes cancer," added Essigmann, who is the senior author of a paper describing the findings in the Journal Proceedings of the National Academy of Sciences.

Regorafenib Drug Improves Survival Rate For Liver Cancer Patients
A phase 3 clinical trial of regorafenib drug for liver cancer treatment was found to improve the survival rate, reveals study.

This approach could also be used to generate profiles for other common carcinogens, said Essigmann.

In the new study, the MIT team set out to see if they could identify mutations produced by aflatoxin long before cancer develops.

New Enzyme Targets for Developing Liver Cancer Drugs
Research findings on unexpected enzyme activity and how liver cancer arises may help to target new drugs for treatment.

First, the researchers exposed mice to a single dose of aflatoxin, four days after birth. After this exposure, all of the mice eventually developed liver cancer.

The researchers sequenced DNA from those tumors and also removed from liver cells; only 10 weeks after exposure, before tumors developed.

To find mutations at 10 weeks, the researchers used a powerful genome sequencing technique that can identify very rare mutations which occur in about one in 10 million to 100 million DNA base pairs.

Unlike most DNA sequencing techniques, the one used in this paper, developed by researchers at the University of Washington, combines data from two complementary strands of DNA.

With the new technique, the researchers found that at 10 weeks, a distinctive pattern of mutations that can serve as a "fingerprint" for aflatoxin exposure had already emerged.

Source-IANS